Dr. Saleh is a biotech entrepreneur having founded and served in a variety of roles in several startup companies, including MIMETAS US, and Nitron Therapeutics prior to miRecule. As an “Entrepreneur in Residence” at BioHealth Innovation, he has consulted for over a dozen biotech companies. In this role, he led technology diligence, market analysis and business and product development efforts. He also participated in funding raises for two companies, and performed scouting efforts for Roche and MedImmune. As the President of MIMETAS US, he raised over $2.5 M in non-dilutive funding and over $1 M in commercial partnerships. Dr. Saleh has more than 20 years of experience in RNA research, and the design of therapeutic oligonucleotides at Johns Hopkins University, The National Institutes of Health, and in the private sector. Dr. Saleh is the lead inventor on miRecule’s discovery platform.